hemangiol
pierre fabre medicament - propranolola hidrohlorīds - hemangioma - beta blocking agents - hemangiol is indicated in the treatment of proliferating infantile haemangioma requiring systemic therapy: , life- or function-threatening haemangioma,, ulcerated haemangioma with pain and/or lack of response to simple wound care measures,, haemangioma with a risk of permanent scars or disfigurement. , it is to be initiated in infants aged 5 weeks to 5 months.
anaprilīns 10 mg tabletes
olainfarm, as, latvia - propranolola hidrohlorīds - tablete - 10 mg
anaprilīns 40 mg tabletes
olainfarm, as, latvia - propranolola hidrohlorīds - tablete - 40 mg
oxybutynin hydrochloride accord 5 mg tabletes
accord healthcare b.v., netherlands - oksibutinīna hidrohlorīds - tablete - 5 mg
ceplene
laboratoires delbert - histamīna dihidrohlorīds - leikēmija, mieloīds, akūts - imunitātes stimulatori, - ceplene maintenance therapy is indicated for adult patients with acute myeloid leukaemia in first remission concomitantly treated with interleukin-2 (il-2). pacientiem, kuri vecāki par 60 gadiem, ceplene efektivitāte nav pilnībā pierādīta.
bioketan 100 mg/ml šķīdums injekcijām
vetoquinol biowet sp. z o.o., polija - ketamīna hidrohlorīds - šķīdums injekcijām - 100 mg/ml - kaķi; suņi
dutasteride/tamsulosin teva 0,5 mg/0,4 mg cietās kapsulas
teva b.v., netherlands - dutasteridum, tamsulosini hydrochloridum - kapsula, cietā - 0,5 mg/0,4 mg
taduzol 0,5 mg/0,4 mg cietās kapsulas
sandoz d.d., slovenia - dutasteridum, tamsulosini hydrochloridum - kapsula, cietā - 0,5 mg/0,4 mg
dutasteride/tamsulosin viatris 0,5 mg/0,4 mg cietās kapsulas
viatris limited, ireland - dutasteridum, tamsulosini hydrochloridum - kapsula, cietā - 0,5 mg/0,4 mg
aduzin 0,5 mg/0,4 mg cietās kapsulas
sandoz d.d., slovenia - dutasteridum, tamsulosini hydrochloridum - kapsula, cietā - 0,5 mg/0,4 mg